Survival and functional outcomes after hemiarthroplasty in children with proximal tibial osteosarcoma.


Journal

Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112

Informations de publication

Date de publication:
03 Oct 2024
Historique:
received: 03 08 2024
accepted: 20 09 2024
medline: 3 10 2024
pubmed: 3 10 2024
entrez: 2 10 2024
Statut: epublish

Résumé

Treatment options for correcting limb-length discrepancy after limb-salvage reconstruction for proximal tibial osteosarcoma in children have several limitations. Therefore, we aimed to evaluate the feasibility, complications, prognosis, and clinical outcomes of reconstruction using hemiarthroplasty after tumor resection in pediatric patients with proximal tibial osteosarcoma. We conducted a comprehensive retrospective analysis of the data of pediatric patients with osteosarcoma of the proximal tibia who underwent surgery between December 2008 and November 2018 at our center. We enrolled 49 consecutive patients who underwent hemiarthroplasty. The cruciate ligaments of all patients were reconstructed using special spacers, and the medial and lateral collateral ligaments of the knee and joint capsule were reconstructed using a mesh. Postoperatively, if the unequal length of both lower limbs exceeded 4 cm or knee instability occurred, a second-stage surgery was performed for limb lengthening and replacing the distal femoral prosthesis. We analyzed the oncological prognosis, complications of hemiarthroplasty, postoperative stability, and postoperative function. The follow-up period ranged between 11 and 159 months, with a median of 84 (62, 129) months. The overall 5-year survival rate was 83.2%. Thirty-nine patients survived at the end of the follow-up period with 34 prostheses (87.2%). The overall prosthesis survival rate was 87.4% after 5 years, indicating the long-term benefits of the procedure. Limb length was measured in 28 adult patients. The average limb-length discrepancy was 33 ± 15 mm with a median of 33 mm (21, 47); the femur and tibia caused a discrepancy of 8.5 ± 9.9 mm and 24.8 ± 15.5 mm, respectively. The patients had 30-135° of knee motion, with a mean of 82 ± 24°. The femoral tibial angle was greater on the affected side than on the healthy side, with a mean difference of 4.5°±3.6°. The Musculoskeletal Tumor Society (MSTS) score was 25 ± 3. Five patients underwent second-stage distal femoral prosthesis replacement, with mean MSTS scores of 24 ± 2 and 28 ± 1 before and after second-stage surgery, respectively. Hemiarthroplasty in children reduces limb-length discrepancy in adulthood by rebuilding cruciate ligaments, lateral collateral ligaments, and the joint capsule, thereby improving knee stability.

Sections du résumé

BACKGROUND BACKGROUND
Treatment options for correcting limb-length discrepancy after limb-salvage reconstruction for proximal tibial osteosarcoma in children have several limitations. Therefore, we aimed to evaluate the feasibility, complications, prognosis, and clinical outcomes of reconstruction using hemiarthroplasty after tumor resection in pediatric patients with proximal tibial osteosarcoma.
METHODS METHODS
We conducted a comprehensive retrospective analysis of the data of pediatric patients with osteosarcoma of the proximal tibia who underwent surgery between December 2008 and November 2018 at our center. We enrolled 49 consecutive patients who underwent hemiarthroplasty. The cruciate ligaments of all patients were reconstructed using special spacers, and the medial and lateral collateral ligaments of the knee and joint capsule were reconstructed using a mesh. Postoperatively, if the unequal length of both lower limbs exceeded 4 cm or knee instability occurred, a second-stage surgery was performed for limb lengthening and replacing the distal femoral prosthesis. We analyzed the oncological prognosis, complications of hemiarthroplasty, postoperative stability, and postoperative function.
RESULTS RESULTS
The follow-up period ranged between 11 and 159 months, with a median of 84 (62, 129) months. The overall 5-year survival rate was 83.2%. Thirty-nine patients survived at the end of the follow-up period with 34 prostheses (87.2%). The overall prosthesis survival rate was 87.4% after 5 years, indicating the long-term benefits of the procedure. Limb length was measured in 28 adult patients. The average limb-length discrepancy was 33 ± 15 mm with a median of 33 mm (21, 47); the femur and tibia caused a discrepancy of 8.5 ± 9.9 mm and 24.8 ± 15.5 mm, respectively. The patients had 30-135° of knee motion, with a mean of 82 ± 24°. The femoral tibial angle was greater on the affected side than on the healthy side, with a mean difference of 4.5°±3.6°. The Musculoskeletal Tumor Society (MSTS) score was 25 ± 3. Five patients underwent second-stage distal femoral prosthesis replacement, with mean MSTS scores of 24 ± 2 and 28 ± 1 before and after second-stage surgery, respectively.
CONCLUSIONS CONCLUSIONS
Hemiarthroplasty in children reduces limb-length discrepancy in adulthood by rebuilding cruciate ligaments, lateral collateral ligaments, and the joint capsule, thereby improving knee stability.

Identifiants

pubmed: 39358763
doi: 10.1186/s13018-024-05103-1
pii: 10.1186/s13018-024-05103-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

619

Subventions

Organisme : Beijing Xisike Clinical Oncology Research Foundation
ID : Y-SY201902-0057

Informations de copyright

© 2024. The Author(s).

Références

Niu X, Xu H, Inwards CY, Li Y, Ding Y, Letson GD, et al. Primary bone tumors: epidemiologic comparison of 9200 patients treated at Beijing Ji Shui Tan Hospital, Beijing, China, with 10 165 patients at Mayo Clinic, Rochester, Minnesota. Arch Pathol Lab Med. 2015;139:1149–55. https://doi.org/10.5858/arpa.2014-0432-OA .
doi: 10.5858/arpa.2014-0432-OA pubmed: 25978765
Mavrogenis AF, Pala E, Angelini A, Ferraro A, Ruggieri P. Proximal tibial resections and reconstructions: clinical outcome of 225 patients. J Surg Oncol. 2013;107:335–42. https://doi.org/10.1002/jso.23216 .
doi: 10.1002/jso.23216 pubmed: 22806768
Medellin MR, Fujiwara T, Clark R, Stevenson JD, Parry M, Jeys L. Mechanisms of failure and survival of total femoral endoprosthetic replacements. Bone Joint J. 2019;101–B(5):522–8. https://doi.org/10.1302/0301-620X.101B5.BJJ-2018-1106.R1 .
doi: 10.1302/0301-620X.101B5.BJJ-2018-1106.R1 pubmed: 31038993
Ness KK, Neel MD, Kaste SC, Billups CA, Marchese VG, Rao BN, et al. A comparison of function after limb salvage with non-invasive expandable or modular prostheses in children. Eur J Cancer. 2014;50:3212–20. https://doi.org/10.1016/j.ejca.2014.10.005 .
doi: 10.1016/j.ejca.2014.10.005 pubmed: 25459397 pmcid: 4303497
Aponte-Tinao LA, Albergo JI, Ayerza MA, Muscolo DL, Ing FM, Farfalli GL. What are the complications of Allograft reconstructions for Sarcoma Resection in children younger than 10 years at long-term followup? Clin Orthop Relat Res. 2018;476:548–55. https://doi.org/10.1007/s11999.0000000000000055 .
doi: 10.1007/s11999.0000000000000055 pubmed: 29529639 pmcid: 6260017
Chung SH, Jeon DG, Cho WH, Song WS, Kong CB, Cho SH, et al. Temporary hemiarthroplasty with a synthetic device in children with osteosarcoma around the knee as a bridging procedure until skeletal maturity. J Surg Oncol. 2015;112:107–14. https://doi.org/10.1002/jso.23964 .
doi: 10.1002/jso.23964 pubmed: 26179818
Benevenia J, Patterson F, Beebe K, Tucker K, Moore J, Ippolito J, et al. Results of 20 consecutive patients treated with the Repiphysis expandable prosthesis for primary malignant bone. Springerplus. 2015;4:793. https://doi.org/10.1186/s40064-015-1582-6 .
doi: 10.1186/s40064-015-1582-6 pubmed: 26702382 pmcid: 4688289
Wu PK, Chen CF, Chen CM, Cheng YC, Tsai SW, Chen TH, et al. Intraoperative extracorporeal irradiation and frozen treatment on Tumor-bearing Autografts Show Equivalent outcomes for Biologic Reconstruction. Clin Orthop Relat Res. 2018;476:877–89. https://doi.org/10.1007/s11999.0000000000000022 .
doi: 10.1007/s11999.0000000000000022 pubmed: 29470232 pmcid: 6260099
Anderson M, Green WT, Messner MB. Growth and predictions of growth in the lower extremities. J Bone Joint Surg Am. 1963;45–A:1–14. https://doi.org/10.2106/00004623-196345010-00001 .
doi: 10.2106/00004623-196345010-00001 pubmed: 14040773
Pritchett JW. Longitudinal growth and growth-plate activity in the lower extremity. Clin Orthop Relat Res. 1992;275:274–9.
doi: 10.1097/00003086-199202000-00041
Cipriano CA, Gruzinova IS, Frank RM, Gitelis S, Virkus WW. Frequent complications and severe bone loss associated with the repiphysis expandable distal femoral prosthesis. Clin Orthop Relat Res. 2015;473:831–8. https://doi.org/10.1007/s11999-014-3564-3 .
doi: 10.1007/s11999-014-3564-3 pubmed: 24664193
Lex JR, Adlan A, Tsoi K, Evans S, Stevenson JD. Frequency and reason for reoperation following non-invasive expandable endoprostheses: a systematic review. J Bone Oncol. 2021;31:100397. https://doi.org/10.1016/j.jbo.2021.100397 .
doi: 10.1016/j.jbo.2021.100397 pubmed: 34712555 pmcid: 8529098
Xu H, Li Y, Yu F, Liu W, Hao L, Zhang Q, et al. An innovative staged prosthetic lengthening reconstruction strategy for osteosarcoma-related leg discrepancy. Sci Rep. 2024;14:717. https://doi.org/10.1038/s41598-023-50422-8 .
doi: 10.1038/s41598-023-50422-8 pubmed: 38184715 pmcid: 10771419
Penna V, Toller EA, Pinheiro C, Becker RG, A NEW APPROACH TO PARTIALKNEE, ENDOPROSTHESIS IN PRIMARY BONE SARCOMAS. Rev Bras Ortop. 2015;44:46–51. https://doi.org/10.1016/S2255-4971(15)30048-3 .
doi: 10.1016/S2255-4971(15)30048-3 pubmed: 26998452 pmcid: 4783592
Lozano-Calderón SA, Kenan S. Total condylar unipolar expandable prosthesis for proximal tibia malignant bone tumors in early childhood. Orthopedics. 2011;34:e899–905. https://doi.org/10.3928/01477447-20111021-05 .
doi: 10.3928/01477447-20111021-05 pubmed: 22146208
Zan P, Shen J, Liu K, Wang H, Cai Z, Ma X, et al. Custom-made semi-joint prosthesis replacement combined ligament advanced reinforcement system (LARS) ligament reconstruction for the limb salvage surgery of malignant tumors in the distal femur in skeletal immature children. Front Pediatr. 2023;11:1168637. https://doi.org/10.3389/fped.2023.1168637 .
doi: 10.3389/fped.2023.1168637 pubmed: 37416814 pmcid: 10320852
Ichikawa J, Matsumoto S, Shimoji T, Ae K, Tanizawa T, Gokita T. A new technique using mesh for extensor reconstruction after proximal tibial resection. Knee. 2015;22:659–63. https://doi.org/10.1016/j.knee.2015.01.001 .
doi: 10.1016/j.knee.2015.01.001 pubmed: 26003215
Liu B, Tan JC, Wang HL, Wu Z, Yuan ZC, Wei CY. The role of mesh technology with tumor prosthesis reconstruction to reconstruct the extensor mechanism of knee joint after resection of proximal tibial tumors. J Orthop Surg Res. 2019;14:64. https://doi.org/10.1186/s13018-019-1105-1 .
doi: 10.1186/s13018-019-1105-1 pubmed: 30808375 pmcid: 6390307
Vavken P, Proffen B, Peterson C, Fleming BC, Machan JT, Murray MM. Effects of suture choice on biomechanics and physeal status after bioenhanced anterior cruciate ligament repair in skeletally immature patients: a large-animal study. Arthroscopy. 2013;29:122–32. https://doi.org/10.1016/j.arthro.2012.07.006 .
doi: 10.1016/j.arthro.2012.07.006 pubmed: 23200845
Mahar AT, Duncan D, Oka R, Lowry A, Gillingham B, Chambers H. Biomechanical comparison of four different fixation techniques for pediatric tibial eminence avulsion fractures. J Pediatr Orthop. 2008;28:159–62. https://doi.org/10.1097/BPO.0b013e318164ee43 .
doi: 10.1097/BPO.0b013e318164ee43 pubmed: 18388708

Auteurs

Yuan Li (Y)

Department of Orthopedic Oncology Surgery, Beijing Jishuitan Hospital, Capital Medical University, No.31 Xin Jie Kou East Street, Xi Cheng District, Beijing, 100035, China.

Hairong Xu (H)

Department of Orthopedic Oncology Surgery, Beijing Jishuitan Hospital, Capital Medical University, No.31 Xin Jie Kou East Street, Xi Cheng District, Beijing, 100035, China.

Yongkun Yang (Y)

Department of Orthopedic Oncology Surgery, Beijing Jishuitan Hospital, Capital Medical University, No.31 Xin Jie Kou East Street, Xi Cheng District, Beijing, 100035, China.

Huachao Shan (H)

Department of Orthopedic Oncology Surgery, Beijing Jishuitan Hospital, Capital Medical University, No.31 Xin Jie Kou East Street, Xi Cheng District, Beijing, 100035, China.

Zhen Huang (Z)

Department of Orthopedic Oncology Surgery, Beijing Jishuitan Hospital, Capital Medical University, No.31 Xin Jie Kou East Street, Xi Cheng District, Beijing, 100035, China.

Ke Ma (K)

Department of Orthopedic Oncology Surgery, Beijing Jishuitan Hospital, Capital Medical University, No.31 Xin Jie Kou East Street, Xi Cheng District, Beijing, 100035, China.

Weifeng Liu (W)

Department of Orthopedic Oncology Surgery, Beijing Jishuitan Hospital, Capital Medical University, No.31 Xin Jie Kou East Street, Xi Cheng District, Beijing, 100035, China.

Xiaohui Niu (X)

Department of Orthopedic Oncology Surgery, Beijing Jishuitan Hospital, Capital Medical University, No.31 Xin Jie Kou East Street, Xi Cheng District, Beijing, 100035, China. niuxiaohui@263.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH